All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...